Resmed (RMD) Other Operating Expenses (2009 - 2026)

Resmed has reported Other Operating Expenses for 18 years, with the latest figure at $11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 3.23% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $46.9 million (up 5.29% YoY), and the FY2023 full-year result was $20.2 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $11.2 million, down from $11.8 million in the prior quarter.
• The five-year high for Other Operating Expenses was $75.8 million in Q4 2023, with the low at $7.7 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $15.3 million across 5 years, with a median of $11.4 million in 2024.
• Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 321.72% — and 2024, when it plunged 85.43%.
• Resmed's Other Operating Expenses stood at $18.0 million in 2022, then jumped by 321.72% to $75.8 million in 2023, then sank by 85.43% to $11.0 million in 2024, then increased by 6.81% to $11.8 million in 2025, then declined by 4.68% to $11.2 million in 2026.
• The last three Other Operating Expenses figures came in at $11.2 million (Q1 2026), $11.8 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.